Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.23382 | 50 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.36753 | 55 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.16841 | 49 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.12703 | 50 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.07597 | 48 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.40056 | 53 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.22613 | 48 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.14491 | 48 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.1395 | 49 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.15714 | 49 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.14397 | 48 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.33532 | 55 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.18452 | 49 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.14826 | 49 |